Biomarkers for prostate cancer: prostate-specific antigen and beyond von Duffy, Michael J.

Volltext

Prognostic and predictive biomarkers in breast cancer: Past, present and future von Nicolini, Andrea, Ferrari, Paola, Duffy, Michael J.

Volltext

Drugging “undruggable” genes for cancer treatment: Are we making progress? von Duffy, Michael J., Crown, John

Volltext

Mutant p53 in breast cancer: potential as a therapeutic target and biomarker von Duffy, Michael J., Synnott, Naoise C., Crown, John

Volltext

Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers von Duffy, Michael J.

Volltext

uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies von Duffy, Michael J, McGowan, Patricia M, Harbeck, Nadia, Thomssen, Christoph, Schmitt, Manfred

Volltext

CA 15-3: Uses and limitation as a biomarker for breast cancer von Duffy, Michael J., Evoy, Denis, McDermott, Enda W.

Volltext

Survivin: A new target for anti-cancer therapy von Ryan, Bríd M, O’Donovan, Norma, Duffy, Michael J

Volltext

The ADAMs family of proteases as targets for the treatment of cancer von Mullooly, Maeve, McGowan, Patricia M., Crown, John, Duffy, Michael J.

Volltext

Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients von Duffy, Michael J, Crown, John

Volltext

Intracellular and Extracellular MicroRNAs in Breast Cancer von CORCORAN, Claire, FRIEL, Anne M, DUFFY, Michael J, CROWN, John, O'DRISCOLL, Lorraine

Volltext

Validation of new cancer biomarkers: a position statement from the European group on tumor markers von Duffy, Michael J, Sturgeon, Catharine M, Sölétormos, György, Barak, Vivian, Molina, Rafael, Hayes, Daniel F, Diamandis, Eleftherios P, Bossuyt, Patrick M M

Volltext

MYC as a target for cancer treatment von Duffy, Michael J., O'Grady, Shane, Tang, Minhong, Crown, John

Volltext

Role of ADAMs in Cancer Formation and Progression von DAFFY, Michael J, MCKIERNAN, Eadaoin, O'DONOVAN, Norma, MCGOWAN, Patricia M

Volltext

ADAM10: a new player in breast cancer progression? von Mullooly, Maeve, McGowan, Patricia M, Kennedy, Susan A, Madden, Stephen F, Crown, John, O' Donovan, Norma, Duffy, Michael J

Volltext

Urokinase Plasminogen Activator and Its Inhibitor, PAI-1, as Prognostic Markers in Breast Cancer: From Pilot to Level 1 Evidence Studies von Duffy, Michael J

Volltext

Use of molecular markers for predicting therapy response in cancer patients von Duffy, Michael J, O’Donovan, Norma, Crown, John

Volltext

Mutant p53 as a target for cancer treatment von Duffy, Michael J., Synnott, Naoise C., Crown, John

Volltext

Targeting p53 for the treatment of cancer von Duffy, Michael J., Synnott, Naoise C., O’Grady, Shane, Crown, John

Volltext

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? von Duffy, Michael J, Mullooly, Maeve, O'Donovan, Norma, Sukor, Sumainizah, Crown, John, Pierce, Aisling, McGowan, Patricia M

Volltext